Eosinophils in COPD: just another biomarker?

Eosinophils in COPD: just another biomarker?

Eosinophils are innate immune cells that, under certain conditions, can be recruited to the lungs, where they have an incompletely understood role in health and disease. Eosinophils have been found in the airways, tissues, and circulation of patients with COPD, during both stable disease and exacerb...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Bafadhel, M, Pavord, I, Russell, R
Format:	Journal article
Język:	English
Wydane:	Elsevier 2017

Podobne zapisy

Copd in the ed: eosinophils, treatment and outcomes, data from the pre-award study
od: Russell, R, i wsp.
Wydane: (2016)

Characterising non-eosinophilic COPD
od: Hambleton, K, i wsp.
Wydane: (2015)

Investigating blood eosinophil count thresholds in patients with COPD
od: Russell, R, i wsp.
Wydane: (2018)

Blood eosinophil levels as a biomarker in COPD
od: Brusselle, G, i wsp.
Wydane: (2018)

Seasonality of eosinophilic and non-eosinophilic exacerbations of COPD
od: Barker, R, i wsp.
Wydane: (2017)

The peripheral blood eosinophil count as a biomarker of eosinophilic airway inflammation in patients with asthma and COPD. Experience from a single centre
od: Shrimanker, R, i wsp.
Wydane: (2017)

Mepolizumab for eosinophilic COPD
od: Sciurba, F, i wsp.
Wydane: (2018)

Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis.
od: Bafadhel, M, i wsp.
Wydane: (2014)

Peripheral blood eosinophil drop-to-drop variation in patients with COPD using near patient testing: a small validation study
od: Jeffers, H, i wsp.
Wydane: (2017)

The significance of eosinophilic inflammation in COPD
od: Cooper, C, i wsp.
Wydane: (2017)

Blood eosinophil count and GOLD stage predict response to maintenance azithromycin treatment in COPD patients with frequent exacerbations
od: Djamin, R, i wsp.
Wydane: (2019)

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
od: Siddiqui, S, i wsp.
Wydane: (2018)

Blood Eosinophils and outcomes in severe hospitalized exacerbations of COPD
od: Bafadhel, M, i wsp.
Wydane: (2016)

Biomarkers in COPD
od: Ramakrishnan, S, i wsp.
Wydane: (2021)

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
od: Siddiqui SH, i wsp.
Wydane: (2018-11-01)

Eosinophil migration is enhanced towards IL-5 and eotaxin in COPD
od: Lababidi, R, i wsp.
Wydane: (2017)

Case series of long-term macrolide therapy effect on eosinophil count in COPD
od: Asciak, R, i wsp.
Wydane: (2017)

Blood eosinophils to guide inhaled maintenance therapy in a primary care COPD population
od: Helen F. Ashdown, i wsp.
Wydane: (2021-02-01)

Can NPT be used to distinguish eosinophilic inflammatory phenotypes in COPD?
od: Hambleton, K, i wsp.
Wydane: (2016)

Blood eosinophil count and exacerbation risk in patients with COPD.
od: Kerkhof, M, i wsp.
Wydane: (2017)

Inhaled glucocorticoids and COPD exacerbations.
od: Brightling, C, i wsp.
Wydane: (2015)

Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease (COPD): A Meta-Analysis of METREX and METREO Exacerbation Endpoints
od: Bafadhel, M, i wsp.
Wydane: (2018)

Sputum Il-17a levels correlate with biomarkers of non-eosinophilic inflammation in patients with asthma
od: Hynes, G, i wsp.
Wydane: (2017)

The acute wheezy adult with airways disease in the emergency department: a retrospective case-note review of exacerbations of COPD
od: Russell, R, i wsp.
Wydane: (2019)

Just another diabetic
od: Rubayet Arefin
Wydane: (2019-11-01)

Just another chalazion?
od: Jonathan McLaughlin, i wsp.
Wydane: (2019-01-01)

Not just another genome
od: Tautz Diethard
Wydane: (2011-02-01)

Blood eosinophil count as a prognostic biomarker in COPD
od: Oh YM, i wsp.
Wydane: (2018-10-01)

The association between blood eosinophils and risk and treatment outcome in COPD is not dichotomised
od: Pascoe, S, i wsp.
Wydane: (2018)

Biomarkers for severe eosinophilic asthma.
od: Yancey, S, i wsp.
Wydane: (2017)

COPD exacerbation severity and frequency is associated with impaired macrophage efferocytosis of eosinophils
od: Eltboli, O, i wsp.
Wydane: (2014)

Shall we focus on the eosinophil to guide treatment with systemic corticosteroids during acute exacerbations of COPD?: PRO
od: Camp, J, i wsp.
Wydane: (2018)

Doxofylline is not just another theophylline!
od: Matera MG, i wsp.
Wydane: (2017-12-01)

Are blood eosinophils a prime-time biomarker for COPD management decisions?
od: Tsiligianni I, i wsp.
Wydane: (2018-06-01)

The acute wheezy adult with airways disease in the emergency department: a retrospective case-note review of exacerbations of COPD
od: Russell REK, i wsp.
Wydane: (2019-05-01)

Association between blood eosinophil count and risk of exacerbations in patients with COPD
od: Kerkhof, M, i wsp.
Wydane: (2017)

Are COPD and cardiovascular disease fundamentally intertwined?
od: Bafadhel, M, i wsp.
Wydane: (2016)

Not Just Another Pretty Picture
od: Hilary Davis
Wydane: (2009-11-01)

Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease (COPD): A Meta-Analysis of METREX and METREO Patient-Reported Outcomes, Response to Therapy and Lung Function
od: Chapman, K, i wsp.
Wydane: (2018)

Shall We Focus on the Eosinophil to Guide Treatment with Systemic Corticosteroids during Acute Exacerbations of COPD?: PRO
od: James Camp, i wsp.
Wydane: (2018-09-01)